
Emerging investigational agents may shift the current standard of care for patients with the rare sarcoma known as gastrointestinal stromal tumors.

Emerging investigational agents may shift the current standard of care for patients with the rare sarcoma known as gastrointestinal stromal tumors.

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as survivorship becomes a key focus.

Chester Freeman shares how the Japanese philosophy of wabi-sabi helped him embrace his scar and find beauty in imperfection while living with leukemia.

Three experts in breast surgery, medical oncology and reconstructive surgery share their insights on the importance of Breast Cancer Awareness Month.

The FDA granted fast track designation to JSKN003 in platinum-resistant recurrent epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer.

Scalp cooling helped Maureen Green feel more like herself during chemotherapy, giving her control over her appearance at a time filled with fear and uncertainty.

My first oncologist got me started with positivity in my cancer journey, which I was, thankfully able to internalize.

During Liver Cancer Awareness Month, Dr. Anjana Pillai says more treatment options, growing trials and ongoing research offer hope for patients.

For Stephanie Wachtel, receiving a diagnosis of triple-positive breast cancer at the age of 23 was life-changing in a number of ways.

Therapies may affect ovarian function and cause early menopause, and many younger women can still pursue family planning with guidance from their care team.

Exousia Pro, Inc. received orphan drug designation from the FDA for malignant glioma, also known as glioblastoma multiforme or GBM.

CURE contributor Ronald D. Chin received a diagnosis of multiple myeloma in 2017 and has been in remission since 2023.

The FDA has approved Blenrep with BVd as a third-line treatment for relapsed or refractory multiple myeloma.

Dr. Sheldon M. Feldman says patients with breast cancer should accept support and make exercise and wellness priorities during treatment to improve outcomes.

CURE spoke with Alyson B. Moadel-Robblee of Montefiore Einstein Center for Cancer Care.

Twanda Frazier guides patients with cancer through Reiki, helping them release stress and find calm, while survivor Radha Narayan shares her positive experience.

CURE spoke with experts about possible side effects faced by patients with breast cancer.

I share how my dog helped me through treatment during the pandemic and how adopting a new one reminds me to keep living and planning for a future beyond cancer.

Dr Anjana Pillai explains screening, imaging and biopsy for liver cancer, why staging matters and which questions help patients understand care.

After a surprise diagnosis at 47, salon owner Christa Messmer found strength, faith and renewed meaning in life while facing colorectal cancer.

Eleven years after surviving breast cancer, I found a new lump that reignited old fears, reminding me that faith and vigilance remain vital to survivorship.

Alyson B. Moadel-Robblee, of Montefiore Einstein Comprehensive Cancer Center discusses the BOLD Program, offering support and wellness resources.

CURE spoke with Alexa M. Lantz of Penn State Health about radiation side effects.

Alecensa cut the risk of death by 22% versus Xalkori, with median overall survival reaching 81.1 months versus 54.2 months in advanced ALK-positive lung cancer.

The FDA granted rare pediatric disease designation to iopofosine-131 for treating relapsed or refractory pediatric high-grade glioma.

Reiki master Twanda Frazier says reiki helps patients with cancer release what no longer serves them and restore emotional and spiritual balance.

Going to a social event two weeks ago gave me perspective on my cancer experience and took me back to my childhood when I never dreamt I’d grapple with the disease.

Until you’re faced with something like cancer some things you thought important become trivial while the under-appreciated become cherished.

The Beamion LUNG-1 study showed that first-line Hernexeos had benefit for patients with HER2-mutated NSCLC.

Dr. Francesca Palandri discusses anemia in myelofibrosis, its impact on survival and quality of life, and the potential of Ojjaara for patients.